The estimated Net Worth of Javan Esfandiari is at least $1.28 Milhão dollars as of 8 October 2021. Mr Esfandiari owns over 73,806 units of Chembio Diagnostics stock worth over $69,121 and over the last 17 years he sold CEMI stock worth over $649,200. In addition, he makes $557,521 as Exec. VP and Chief Science & Technology Officer at Chembio Diagnostics.
Sign up
Mr Esfandiari CEMI stock SEC Form 4 insiders trading
Mr has made over 10 trades of the Chembio Diagnostics stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 73,806 units of CEMI stock worth $33,951 on 8 October 2021.
The largest trade he's ever made was selling 80,000 units of Chembio Diagnostics stock on 7 December 2011 worth over $32,000. On average, Mr trades about 9,902 units every 117 days since 2008. As of 8 October 2021 he still owns at least 150,264 units of Chembio Diagnostics stock.
You can see the complete history of Mr Esfandiari stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Javan Esfandiari biography
Javan Esfandiari is the Exec. VP and Chief Science & Technology Officer at Chembio Diagnostics.
What is the salary of Mr Esfandiari?
As the Exec. VP and Chief Science & Technology Officer of Chembio Diagnostics, the total compensation of Mr Esfandiari at Chembio Diagnostics is $557,521. There are no executives at Chembio Diagnostics getting paid more.
How old is Mr Esfandiari?
Mr Esfandiari is 54, he's been the Exec. VP and Chief Science & Technology Officer of Chembio Diagnostics since . There are 5 older and 2 younger executives at Chembio Diagnostics. The oldest executive at Chembio Diagnostics Inc. is Mary Polan, 76, who is the Independent Director.
What's Mr Esfandiari's mailing address?
Javan's mailing address filed with the SEC is C/O CHEMBIO DIAGNOSTICS, INC., 3661 HORSEBLOCK ROAD, MEDFORD, NY, 11763.
Insiders trading at Chembio Diagnostics
Over the last 20 years, insiders at Chembio Diagnostics have traded over $909,824 worth of Chembio Diagnostics stock and bought 3,754,893 units worth $1,696,058 . The most active insiders traders include Credit Advisors, Llcpercept..., Lawrence A. Siebert, eRichard Eberly. On average, Chembio Diagnostics executives and independent directors trade stock every 90 days with the average trade being worth of $36,203. The most recent stock trade was executed by Credit Advisors, Llcpercept... on 21 April 2023, trading 243,448 units of CEMI stock currently worth $109,552.
What does Chembio Diagnostics do?
Chembio is a leading point-of-care diagnostics company focused on detecting and diagnosing infectious diseases, including COVID-19, sexually transmitted disease, and fever and tropical disease. Coupled with Chembio's extensive scientific expertise, its novel DPP technology offers broad market applications beyond infectious disease. Chembio's products are sold globally, directly and through distributors, to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers.
What does Chembio Diagnostics's logo look like?
Complete history of Mr Esfandiari stock trades at Chembio Diagnostics
Chembio Diagnostics executives and stock owners
Chembio Diagnostics executives and other stock owners filed with the SEC include:
-
Javan Esfandiari,
Exec. VP and Chief Science & Technology Officer -
Richard L. Eberly,
Pres, CEO & Director -
Javan Esfandiari,
Executive Vice President, Chief Scientific And Technology Officer -
Neil Goldman,
Chief Financial Officer, Executive Vice President -
Katherine Davis,
Independent Director -
John Potthoff,
Independent Director -
Gail Page,
Executive Chairman of the Board -
Mary Polan,
Independent Director -
Lynn Lewis,
Investor Relations Contact Officer -
Chuck Caso,
Vice President of Sales and Marketing for North America -
Richard Eberly,
President, Chief Executive Officer, Director -
Stella Rivera,
VP of HR -
Atif Rizvi,
VP of Fin. -
Dr. Konstantin Lyashchenko,
Research Director of Chembio Diagnostic Systems Inc -
Charles Caso,
VP of Sales & Marketing -
Paul J. Angelico,
VP of Global Operations -
Peter Kissinger,
Director -
Richard J Larkin,
Chief Financial Officer -
Barbara A De Buono,
Director -
John J Iii Sperzel,
CEO -
Robert L Aromando,
Sr VP, Commercial Operations -
Alan Carus,
Director -
Lawrence A. Siebert,
President -
Leslie Teso Lichtman,
-
Norman H Pessin Brian L. Pe...,
-
Gary Meller,
Director -
Sharon W Klugewicz,
Chief Operating Officer -
David Gyorke,
See Remarks -
Robert Passas,
See Remarks -
Avi Pelossof,
Vice President -
Gerald A Eppner,
Director -
James D Merselis,
Director -
Capital Master Llc Crestvie...,
-
David Acheson,
-
Credit Advisors, Llcpercept...,
-
David William Bespalko,
-
Lawrence J. Steenvoorden,
See remarks -
Charles Caso,
See Remarks -
Paul Angelico,
See remarks